AI-Native Scoping Reviews & Evidence Mapping

ISSN 3054-3991 · ISSN record ↗
The Journal publishes machine-generated scoping reviews in medical and life sciences under human-editorial oversight, with transparent citations and versioning. Online First articles are continuously released by registered users. Issues are organized by domain and linked to an interactive AI RAG chatbot.
Editor's Choice papers are marked with .

Read aims & scope, publishing model & policies →

Issues

Domain issues provide a same-page filtered article view and a paired RAG agent.

Cardiac & Vascular Health

Issue 1 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

Longevity & Public Health

Issue 2 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

Digital Health

Issue 3 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

Mental Health

Issue 4 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

Sports Medicine

Issue 5 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

Pain Medicine

Issue 6 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

Infectious Diseases

Issue 7 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

Skin & Aesthetics

Issue 8 • Vol 1 (2026) in progress

Issue articles → Chat with this issue →

To propose a new domain issue or suggest curation criteria, use Impressum contact.

Hantavirus Infection: Scoping Review with ☸️SAIMSARA.

Infectious Diseases

Hantavirus infection is not just a rare rodent-borne fever: this evidence map shows it as a multisystem vascular infection driven by ecology, endothelial dysfunction, thrombocytopenia, and renal or cardiopulmonary injury. The full SAIMSARA paper and machine-readable JSON provide structured, reference-linked evidence across 1,084 original studies, covering diagnosis, exposure risk, Andes-virus transmission, severity markers, One Health surveillance, and the still-unproven therapeutic frontier.

Updated: 2026-05-11 • ID: hantavirus-infection-20260511-091717-12cb6553 • Editorial check 2026-05-11

Open (journal link) → · Direct source →

COVID-19 Vaccine and Mortality: Scoping Review with ☸️SAIMSARA.

Infectious Diseases

This review shows that COVID-19 vaccination was generally linked to lower mortality, especially in older and high-risk groups, but that protection decreased over time and improved again after booster doses. Read the full paper to see where the evidence is strongest, which groups benefit most, and where important safety and interpretation questions remain.

Updated: 2026-05-11 • ID: covid-vaccine-mortality-20251026-192337-047981e6

Open (journal link) → · Direct source →

COVID-19 Vaccine and Complications: Scoping Review with ☸️SAIMSARA.

Infectious Diseases

This review maps a large clinical evidence base showing that COVID-19 vaccines were generally linked to a strong safety-benefit balance: serious complications such as myocarditis and VITT were rare, while protection against severe COVID-19 outcomes and death remained substantial. Read the full paper to see which risks were truly recurrent, which populations were most vulnerable, and how the balance differed by vaccine platform, age, pregnancy, chronic disease, and immunocompromised status.

Updated: 2026-05-11 • ID: covid-vaccine-complications-20251021-194236-04bd8801

Open (journal link) → · Direct source →